RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Prion Diseases
  Small Pox
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Leishmaniasis Channel

subscribe to Leishmaniasis newsletter
Latest Research : Infectious Diseases : Leishmaniasis

   EMAIL   |   PRINT
Vaccine developed to fight black fever

Apr 25, 2006 - 8:38:00 PM , Reviewed by: Priya Saxena
The Swiss team is now moving on towards testing the vaccine on animals.

[RxPG] Swiss scientists have developed a vaccine that could protect animals and humans from Leishmaniasis, or black fever, a parasitic disease that kills about 60,000 people a year.

Leishmaniasis, spread by the bite of the sandfly, attacks the spleen, bone marrow and liver and destroys the immune system. Untreated, it is nearly always fatal.

No vaccine yet exists for the disease that affects 500,000 people worldwide each year - mostly in India, Bangladesh, Nepal, Sudan and Brazil.

The vaccine, designed by researchers at the Laboratory for Organic Chemistry at the Swiss Federal Institute of Technology (ETH), Zurich, uses synthetic forms of carbohydrates taken from the parasite or bacteria responsible for the disease.

Laboratory studies have shown that the possible vaccine designed by the team produces a protective action against Leishmaniasis, stimulating the patient's own immune system, reported the online edition of BBC News.

The Swiss team is now moving on towards testing the vaccine on animals.

However, they say the vaccine development is in an early stage. Animal tests will take two years and pre-clinical trials another two to three years. A final vaccine is at least five years off, one researcher said.

Among common symptoms of the disease are lesions on the skin, persistent fever, night sweats, fatigue, weakness, appetite loss, vomiting and diarrhoea in children and cough.

There are about half a million new cases of visceral Leishmaniasis occurring each year.

The disease currently does not have any effective treatment. The most common drugs used to treat the disease have serious side effects and are expensive.

Publication: Indo-Asian News Service

Advertise in this space for $10 per month. Contact us today.

Related Leishmaniasis News
Vaccine developed to fight black fever
Potential vaccine developed for deadly leishmaniasis disease
Drug-Resistant Leishmania tropica Parasites Detected in Iranian Cutaneous Leishmaniasis

Subscribe to Leishmaniasis Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)